Aprepitant

What is Aprepitant?

Aprepitant is a prescription medication used to help prevent nausea and vomiting associated with certain medical treatments and procedures.

Drug class: Aprepitant belongs to a class of medications known as neurokinin-1 (NK1) receptor antagonists. It works differently from older antiemetic (anti-nausea) medications by targeting a specific pathway in the brain involved in the vomiting reflex.

Common approved and prescribed uses include:

• Prevention of nausea and vomiting associated with chemotherapy treatments (both the immediate and delayed phases)
• Prevention of postoperative nausea and vomiting following certain surgical procedures

Available formulations and strengths: Aprepitant is available in several forms, which may include:

• Oral capsules (commonly available in strengths such as 40 mg, 80 mg, and 125 mg, often provided as part of a multi-day dose pack for chemotherapy regimens)
• Oral suspension
• An intravenous (IV) prodrug form (fosaprepitant) used in some clinical settings

Not all formulations or strengths are available in every market. The specific product and regimen prescribed will depend on the treatment plan developed by the patient’s care team.

What is the Recommended Dosage of Aprepitant?

Dosage of aprepitant is individualized and is not appropriate to determine without professional guidance. Dosing depends on several factors, including:

• Condition being treated (chemotherapy-induced nausea vs. postoperative nausea)
• The specific chemotherapy regimen and its emetogenic (nausea-causing) potential
• Age of the patient
• Body weight, in certain treatment plans
• Organ function, since liver impairment can affect how the medication is processed

Aprepitant for chemotherapy-related nausea is often prescribed as part of a multi-day regimen, sometimes combined with other antiemetic medications, and timed relative to chemotherapy administration.

Because dosing is closely tied to a specific treatment protocol, this page does not provide a general dosing chart. Dosing must be determined and confirmed by the prescribing oncologist, surgeon, or other licensed medical specialist managing the patient’s care.

How Aprepitant Works

Aprepitant works by blocking neurokinin-1 (NK1) receptors in the brain. Substance P, a chemical messenger in the body, binds to these receptors and plays a key role in triggering nausea and vomiting, particularly the delayed nausea that can occur days after chemotherapy. By blocking this pathway, aprepitant helps reduce the frequency and severity of nausea and vomiting.

It is important to understand that aprepitant helps prevent and manage nausea and vomiting related to specific triggers — it does not treat the underlying condition being managed with chemotherapy or surgery, and it is typically used alongside other antiemetic medications as part of a broader treatment plan.

Is a Prescription Required to Buy Aprepitant Online?

Yes. Aprepitant is a prescription-only medication. It is not available over the counter.

Patients should only obtain aprepitant under the direction of a licensed medical specialist, such as an oncologist (for chemotherapy-related nausea) or the surgical/anesthesia team (for postoperative nausea), who can determine the appropriate regimen based on the specific treatment being received.

Important safety notes:

• Only purchase medication from licensed, reputable pharmacies.
• Avoid counterfeit products, particularly when purchasing online.
• Never use products not specifically prescribed for the patient’s situation.
• Verify that any online pharmacy is properly licensed and requires a valid prescription.

Side Effects of Aprepitant

Common Side Effects

These are typically mild and may include:

• Fatigue or weakness
• Headache
• Hiccups
• Diarrhea or constipation
• Decreased appetite

Serious Side Effects

Though uncommon, some side effects can be serious and require prompt medical attention, including:

• Signs of an allergic reaction (swelling of the face, lips, tongue, or throat; difficulty breathing; hives; severe skin reactions)
• Severe or persistent abdominal pain
• Signs of liver problems, such as yellowing of the skin or eyes, dark urine, or unusual fatigue

Seek immediate medical attention if any of these serious symptoms occur. This list is not exhaustive, and patients should report any unusual or concerning symptoms to their oncology or medical team promptly, since they are often already in close contact with a care team during treatment.

Drug Interactions

Aprepitant can interact with a range of other medications because it affects certain liver enzymes involved in drug metabolism. Categories of concern include:

• Chemotherapy agents — aprepitant may affect the levels of certain chemotherapy drugs, requiring careful coordination by the oncology team
• Hormonal contraceptives — aprepitant may reduce the effectiveness of hormonal birth control; alternative or additional contraception may be recommended during and after treatment
• Blood thinners (such as warfarin) — aprepitant may affect blood clotting parameters, requiring closer monitoring
• Certain other medications metabolized by the liver, including some sedatives, corticosteroids, and other prescription drugs

Over-the-counter medications and supplements: Some OTC products and herbal supplements, such as St. John’s Wort, can also interact with aprepitant. Patients should not assume any supplement is automatically safe to combine with this medication.

Patients should always provide a complete and current list of all prescription medications, OTC drugs, vitamins, and herbal supplements to their oncologist, surgeon, or other licensed medical specialist before starting aprepitant.

Safety & Important Considerations

• Liver disease: Because aprepitant is processed by the liver, patients with liver impairment may require closer monitoring or dose adjustments.
• Kidney disease: Kidney function is generally less of a concern with aprepitant, but any relevant conditions should still be discussed with the care team.
• Pregnancy and breastfeeding: Patients who are pregnant, planning pregnancy, or breastfeeding should discuss the risks and benefits of aprepitant with their treatment team, as safety data in these situations may be limited.
• Hormonal contraception: Due to potential interactions, patients using hormonal birth control should discuss alternative or backup contraception with their provider during and for a period after treatment.
• Age-related considerations: Use in children and older adults should be guided by a specialist familiar with the patient’s overall treatment plan.
• Monitoring requirements: Patients undergoing chemotherapy are typically already monitored closely; any additional monitoring related to aprepitant, such as liver function tests, will be determined by the treatment team.

Patients should review current prescribing information and any applicable safety communications with their healthcare provider or pharmacist, as safety guidance can be updated over time.

Who This Medication Is For

Aprepitant is generally intended for individuals who are:

• Undergoing chemotherapy treatments known to cause nausea and vomiting, as part of a preventive antiemetic regimen
• Undergoing certain surgical procedures where postoperative nausea and vomiting prevention is appropriate, as determined by the surgical or anesthesia team

Suitability depends on the specific treatment plan, individual health history, and any existing medical conditions, particularly liver function.

Who Should Not Take Aprepitant

Aprepitant may not be appropriate for individuals with certain conditions. Potential contraindications and precautions include:

• Known allergy or hypersensitivity to aprepitant, fosaprepitant, or their components
• Concurrent use of certain medications that have significant interactions with aprepitant, as determined by the prescribing specialist
• Severe liver impairment, which may require alternative approaches or careful specialist oversight
• Use of hormonal contraception as the sole method of birth control without additional backup, due to reduced effectiveness during treatment

This is not a complete list. A licensed medical specialist should review a patient’s full medical history and current medications before prescribing aprepitant.

What to Do If You Miss a Dose

Because aprepitant is often used as part of a structured, time-sensitive regimen around chemotherapy or surgery:

• Contact the prescribing oncology team, surgical team, or pharmacist as soon as possible if a dose is missed.
• Do not double the dose to make up for a missed one without specific instruction.
• Do not attempt to adjust the regimen independently, since timing relative to chemotherapy or surgery is often clinically important.

Given the specialized nature of this medication’s use, missed doses should always be reported to the care team managing the treatment.

Related medications to Aprepitant

Other medications used for chemotherapy-related or postoperative nausea and vomiting, depending on the clinical situation, may include:

• Other NK1 receptor antagonists (such as fosaprepitant or netupitant, sometimes combined with palonosetron)
• 5-HT3 receptor antagonists (such as ondansetron or granisetron)
• Corticosteroids (such as dexamethasone), often used in combination regimens
• Other antiemetic medications, depending on the underlying cause and treatment protocol

These alternatives have their own risks, benefits, and appropriate uses, and are often used in combination rather than as direct substitutes. Switching or adjusting antiemetic regimens should only be done in consultation with the prescribing oncologist, surgeon, or other licensed medical specialist.

Storage Instructions

• Store at room temperature, generally away from excessive heat or cold, following the guidance on the product packaging.
• Protect from excess moisture and direct light.
• Keep the medication in its original, tightly closed container.
• Store out of reach and sight of children and pets to prevent accidental ingestion.
• Dispose of expired or unused medication according to local guidelines or pharmacy take-back programs.

Disclaimer:

This page is for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Patients must consult a licensed medical specialist — such as an oncologist, surgeon, or pharmacist — before starting, changing, or stopping treatment with aprepitant. Treatment decisions must be based on a full clinical evaluation by a qualified healthcare provider.